Inventor
GILLMAN KEVIN W
US17 patents
⚠️ This page may combine multiple inventors who share the name “GILLMAN KEVIN W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
13 patentsUS10633419B2Apr 28, 2020
Immunomodulators
BRISTOL MYERS SQUIBB CO7 citations84
US9856292B2Jan 2, 2018
Immunomodulators
BRISTOL MYERS SQUIBB CO12 citations84
US10538555B2Jan 21, 2020
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
BRISTOL MYERS SQUIBB CO8 citations83
US11358988B2Jun 14, 2022
Immunomodulators
BRISTOL MYERS SQUIBB CO2 citations73
US11952434B2Apr 9, 2024
Immunomodulators
BRISTOL MYERS SQUIBB CO0 citations62
US11066445B2Jul 20, 2021
Immunomodulators acting as antagonists of PD-1
BRISTOL MYERS SQUIBB CO2 citations62
US10988507B2Apr 27, 2021
Immunomodulators
BRISTOL MYERS SQUIBB CO2 citations62
USRE49735ENov 28, 2023
Oxazolidinones as modulators of MGLUR5
BRISTOL MYERS SQUIBB CO0 citations60
US6930100B2Aug 16, 2005
Phosphate prodrugs of fluoroxindoles
BRISTOL MYERS SQUIBB CO2 citations55
US8350084B2Jan 8, 2013
Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
BRISTOL MYERS SQUIBB CO0 citations52
US8044077B2Oct 25, 2011
Alpha-(N-sulfonamido)acetamide compounds incorporating deuterium as inhibitors of beta amyloid peptide production
BRISTOL MYERS SQUIBB CO1 citations52
US8383821B2Feb 26, 2013
NK-1 and serotonin transporter inhibitors
BRISTOL MYERS SQUIBB CO0 citations39
US7091202B2Aug 15, 2006
4-arylspirocycloalkyl-2-aminopyrimidine carboxamide KCNQ potassium channel modulators
BRISTOL MYERS SQUIBB CO0 citations36